INNOVIVA INC (INVA) Stock Fundamental Analysis
USA - NASDAQ:INVA - US45781M1018 - Common Stock
17.4 USD
+0.19 (+1.1%)
17.4 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to INVA. INVA was compared to 191 industry peers in the Pharmaceuticals industry. INVA gets an excellent profitability rating and is at the same time showing great financial health properties. INVA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make INVA a good candidate for value and quality investing.
1. Profitability
1.1 Basic Checks
In the past year INVA was profitable.
INVA had a positive operating cash flow in the past year.
Each year in the past 5 years INVA has been profitable.
In the past 5 years INVA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of INVA (2.90%) is better than 84.82% of its industry peers.
Looking at the Return On Equity, with a value of 5.41%, INVA belongs to the top of the industry, outperforming 84.82% of the companies in the same industry.
INVA has a better Return On Invested Capital (12.60%) than 90.05% of its industry peers.
INVA had an Average Return On Invested Capital over the past 3 years of 11.38%. This is below the industry average of 15.45%.
The 3 year average ROIC (11.38%) for INVA is below the current ROIC(12.60%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 5.41% | ||
| ROIC | 12.6% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
1.3 Margins
Looking at the Profit Margin, with a value of 10.44%, INVA belongs to the top of the industry, outperforming 85.86% of the companies in the same industry.
In the last couple of years the Profit Margin of INVA has declined.
With an excellent Operating Margin value of 47.69%, INVA belongs to the best of the industry, outperforming 98.95% of the companies in the same industry.
In the last couple of years the Operating Margin of INVA has declined.
INVA has a Gross Margin of 86.60%. This is amongst the best in the industry. INVA outperforms 90.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 47.69% | ||
| PM (TTM) | 10.44% | ||
| GM | 86.6% |
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
INVA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
INVA has less shares outstanding than it did 1 year ago.
INVA has less shares outstanding than it did 5 years ago.
INVA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.16 indicates that INVA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.16, INVA is in the better half of the industry, outperforming 65.97% of the companies in the same industry.
The Debt to FCF ratio of INVA is 2.29, which is a good value as it means it would take INVA, 2.29 years of fcf income to pay off all of its debts.
INVA has a Debt to FCF ratio of 2.29. This is amongst the best in the industry. INVA outperforms 92.15% of its industry peers.
INVA has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of INVA (0.36) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.29 | ||
| Altman-Z | 2.16 |
ROIC/WACC1.62
WACC7.79%
2.3 Liquidity
INVA has a Current Ratio of 2.64. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
INVA has a Current ratio of 2.64. This is comparable to the rest of the industry: INVA outperforms 50.26% of its industry peers.
INVA has a Quick Ratio of 2.44. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of INVA (2.44) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.64 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
INVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.21%.
The earnings per share for INVA have been decreasing by -33.21% on average. This is quite bad
Looking at the last year, INVA shows a quite strong growth in Revenue. The Revenue has grown by 12.01% in the last year.
INVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.57% yearly.
EPS 1Y (TTM)-81.21%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%240%
Revenue 1Y (TTM)12.01%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%0.39%
3.2 Future
Based on estimates for the next years, INVA will show a very strong growth in Earnings Per Share. The EPS will grow by 83.16% on average per year.
Based on estimates for the next years, INVA will show a quite strong growth in Revenue. The Revenue will grow by 12.04% on average per year.
EPS Next Y526.32%
EPS Next 2Y242.88%
EPS Next 3Y133.78%
EPS Next 5Y83.16%
Revenue Next Year7.36%
Revenue Next 2Y9.46%
Revenue Next 3Y9.65%
Revenue Next 5Y12.04%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 56.13, which means the current valuation is very expensive for INVA.
Based on the Price/Earnings ratio, INVA is valued a bit cheaper than the industry average as 77.49% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.77, INVA is valued quite expensively.
A Price/Forward Earnings ratio of 7.79 indicates a rather cheap valuation of INVA.
Based on the Price/Forward Earnings ratio, INVA is valued cheaper than 88.48% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of INVA to the average of the S&P500 Index (23.23), we can say INVA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.13 | ||
| Fwd PE | 7.79 |
4.2 Price Multiples
INVA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INVA is cheaper than 98.95% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INVA is valued cheaply inside the industry as 95.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.58 | ||
| EV/EBITDA | 4.38 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVA has a very decent profitability rating, which may justify a higher PE ratio.
INVA's earnings are expected to grow with 133.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y242.88%
EPS Next 3Y133.78%
5. Dividend
5.1 Amount
No dividends for INVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
17.4
+0.19 (+1.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners122.15%
Inst Owner Change-0.08%
Ins Owners1.05%
Ins Owner Change1.25%
Market Cap1.10B
Analysts80
Price Target41.82 (140.34%)
Short Float %10.6%
Short Ratio8.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-149.59%
Min EPS beat(2)-350.17%
Max EPS beat(2)50.98%
EPS beat(4)1
Avg EPS beat(4)-105.72%
Min EPS beat(4)-350.17%
Max EPS beat(4)50.98%
EPS beat(8)4
Avg EPS beat(8)-13.41%
EPS beat(12)6
Avg EPS beat(12)-52.11%
EPS beat(16)7
Avg EPS beat(16)-44.13%
Revenue beat(2)2
Avg Revenue beat(2)5.97%
Min Revenue beat(2)5.11%
Max Revenue beat(2)6.82%
Revenue beat(4)4
Avg Revenue beat(4)7.43%
Min Revenue beat(4)3.7%
Max Revenue beat(4)14.09%
Revenue beat(8)7
Avg Revenue beat(8)8.9%
Revenue beat(12)10
Avg Revenue beat(12)4.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.65%
EPS NQ rev (1m)-4.66%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)12.54%
EPS NY rev (3m)74.13%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)4.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.13 | ||
| Fwd PE | 7.79 | ||
| P/S | 2.96 | ||
| P/FCF | 5.58 | ||
| P/OCF | 5.47 | ||
| P/B | 1.53 | ||
| P/tB | 2.5 | ||
| EV/EBITDA | 4.38 |
EPS(TTM)0.31
EY1.78%
EPS(NY)2.23
Fwd EY12.84%
FCF(TTM)3.12
FCFY17.91%
OCF(TTM)3.18
OCFY18.3%
SpS5.87
BVpS11.34
TBVpS6.96
PEG (NY)0.11
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 5.41% | ||
| ROCE | 16.24% | ||
| ROIC | 12.6% | ||
| ROICexc | 23.24% | ||
| ROICexgc | 43.77% | ||
| OM | 47.69% | ||
| PM (TTM) | 10.44% | ||
| GM | 86.6% | ||
| FCFM | 53.03% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
ROICexc(3y)16.17%
ROICexc(5y)24.46%
ROICexgc(3y)28.95%
ROICexgc(5y)34.96%
ROCE(3y)14.67%
ROCE(5y)23.41%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y-15.28%
ROICexc growth 3Y-21.15%
ROICexc growth 5Y-17.48%
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.29 | ||
| Debt/EBITDA | 1.19 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 17.04 | ||
| Cash Conversion | 92.65% | ||
| Profit Quality | 508.02% | ||
| Current Ratio | 2.64 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 2.16 |
F-Score5
WACC7.79%
ROIC/WACC1.62
Cap/Depr(3y)4.13%
Cap/Depr(5y)2.48%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.27%
Profit Quality(3y)320.3%
Profit Quality(5y)247.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-81.21%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%240%
EPS Next Y526.32%
EPS Next 2Y242.88%
EPS Next 3Y133.78%
EPS Next 5Y83.16%
Revenue 1Y (TTM)12.01%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%0.39%
Revenue Next Year7.36%
Revenue Next 2Y9.46%
Revenue Next 3Y9.65%
Revenue Next 5Y12.04%
EBIT growth 1Y29.9%
EBIT growth 3Y-23.66%
EBIT growth 5Y-7.5%
EBIT Next Year-6.31%
EBIT Next 3Y-8.15%
EBIT Next 5YN/A
FCF growth 1Y122.11%
FCF growth 3Y-20.27%
FCF growth 5Y-6.46%
OCF growth 1Y126.68%
OCF growth 3Y-19.65%
OCF growth 5Y-6.03%